{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Faricimab (RO6867461)",
        "type": {
          "id": "0b6cf6a4-5c16-4a0e-b272-fb1265f49351",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "3c97eb05-c89d-4424-bd8b-32945d9dd219",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Bispecific antibody targeting Ang-2 and VEGF for the treatment of macular edema secondary to BRVO.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Aflibercept",
        "type": {
          "id": "9fe32940-9218-41f1-a94a-c217014bffb2",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "e69dafdc-7369-47a2-8341-309cfe354540",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Active comparator (anti-VEGF monotherapy) for Part 1 of the study.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Sham procedure",
        "type": {
          "id": "de0f3222-40f2-4758-9711-b0fe21d6907a",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "role": {
          "id": "c1ec334a-d634-4e11-88f1-424e09449e29",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Procedure mimicking an IVT injection using the blunt end of an empty syringe to maintain masking during Part 2.",
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Systemic corticosteroids",
        "type": {
          "id": "a942cf1f-ba77-47d2-a2fe-fba2df897a10",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "d089e308-52d0-45c3-84e5-e65ec6d0a0e0",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 1 month of screening and during the study."
      },
      {
        "id": "int_5",
        "name": "Anti-VEGF IVT",
        "type": {
          "id": "d58f41a6-292b-4a5f-9225-bcc9fa4980cd",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "577f8f69-00e3-4628-9fb8-e6a1b07713cd",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prior treatment for macular edema due to RVO is a reason for exclusion (washout/prior medication)."
      },
      {
        "id": "int_6",
        "name": "Prophylactic antibiotic therapy",
        "type": {
          "id": "51d9a893-0515-4198-b10e-80fb3e3877c5",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "ee38aba1-3783-44fa-845a-e0ac0934900a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted if approved by the Medical Monitor."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Faricimab",
        "administrableDoseForm": {
          "id": "ecb8542f-128b-401d-9910-93e4fcab0e3d",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "b0a85a42-c1c3-48e3-a7cf-776ca9832b7d",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "1ead69a8-c87d-4ea0-b93a-c1664835a31f",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "6 mg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "F. Hoffmann-La Roche Ltd"
      },
      {
        "id": "prod_2",
        "name": "Aflibercept",
        "administrableDoseForm": {
          "id": "a8a2d052-09b2-4232-bbbe-7c1711694550",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "24379bfd-e295-4fce-a936-f4a3731d69eb",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "e6972aff-1fc0-4441-8aa1-d6aef2f45c43",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "2 mg",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Not specified"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Faricimab Part 1",
        "instanceType": "Administration",
        "dose": "6 mg",
        "doseFrequency": "every 4 weeks",
        "route": {
          "code": "Other",
          "codeSystem": "USDM",
          "decode": "Other"
        },
        "duration": "Day 1 through Week 20 (6 injections)"
      },
      {
        "id": "admin_2",
        "name": "Aflibercept Part 1",
        "instanceType": "Administration",
        "dose": "2 mg",
        "doseFrequency": "every 4 weeks",
        "route": {
          "code": "Other",
          "codeSystem": "USDM",
          "decode": "Other"
        },
        "duration": "Day 1 through Week 20 (6 injections)"
      },
      {
        "id": "admin_3",
        "name": "Faricimab Part 2 (PTI)",
        "instanceType": "Administration",
        "dose": "6 mg",
        "doseFrequency": "every 4 weeks to every 16 weeks",
        "route": {
          "code": "Other",
          "codeSystem": "USDM",
          "decode": "Other"
        },
        "duration": "Week 24 through Week 68"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Faricimab",
        "instanceType": "Substance",
        "description": "Bispecific antibody (RO6867461)"
      },
      {
        "id": "sub_2",
        "name": "Aflibercept",
        "instanceType": "Substance",
        "description": "VEGF trap protein"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 6,
      "productCount": 2,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Faricimab (RO6867461)",
        "role": "Investigational Product",
        "description": "Bispecific antibody targeting Ang-2 and VEGF for the treatment of macular edema secondary to BRVO."
      },
      {
        "name": "Aflibercept",
        "role": "Comparator",
        "description": "Active comparator (anti-VEGF monotherapy) for Part 1 of the study."
      },
      {
        "name": "Sham procedure",
        "role": "Placebo",
        "description": "Procedure mimicking an IVT injection using the blunt end of an empty syringe to maintain masking during Part 2."
      },
      {
        "name": "Systemic corticosteroids",
        "role": "Concomitant Medication",
        "description": "Prohibited within 1 month of screening and during the study."
      },
      {
        "name": "Anti-VEGF IVT",
        "role": "Concomitant Medication",
        "description": "Prior treatment for macular edema due to RVO is a reason for exclusion (washout/prior medication)."
      },
      {
        "name": "Prophylactic antibiotic therapy",
        "role": "Concomitant Medication",
        "description": "Permitted if approved by the Medical Monitor."
      }
    ],
    "products": [
      {
        "name": "Faricimab",
        "doseForm": "Injection",
        "strength": "6 mg",
        "manufacturer": "F. Hoffmann-La Roche Ltd"
      },
      {
        "name": "Aflibercept",
        "doseForm": "Injection",
        "strength": "2 mg",
        "manufacturer": "Not specified"
      }
    ],
    "substances": [
      {
        "name": "Faricimab",
        "description": "Bispecific antibody (RO6867461)"
      },
      {
        "name": "Aflibercept",
        "description": "VEGF trap protein"
      }
    ],
    "administrations": [
      {
        "name": "Faricimab Part 1",
        "dose": "6 mg",
        "frequency": "every 4 weeks",
        "route": "Intravitreal",
        "duration": "Day 1 through Week 20 (6 injections)"
      },
      {
        "name": "Aflibercept Part 1",
        "dose": "2 mg",
        "frequency": "every 4 weeks",
        "route": "Intravitreal",
        "duration": "Day 1 through Week 20 (6 injections)"
      },
      {
        "name": "Faricimab Part 2 (PTI)",
        "dose": "6 mg",
        "frequency": "every 4 weeks to every 16 weeks",
        "route": "Intravitreal",
        "duration": "Week 24 through Week 68"
      }
    ],
    "devices": []
  }
}